Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer

NCT01628757 is registered in ClinicalTrials.gov with Ding Ma as lead sponsor.

NCT NCT01628757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01628757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer
Lead sponsor
Ding Ma
Phase
Observational
Overall status
Unknown status
Start date
Not reported
Completion date
December 31, 2023
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer